157 related articles for article (PubMed ID: 31480599)
1. Preparation, Characterization, and Inhibition of Hyaluronic Acid Oligosaccharides in Triple-Negative Breast Cancer.
Han W; Song L; Wang Y; Lv Y; Chen X; Zhao X
Biomolecules; 2019 Sep; 9(9):. PubMed ID: 31480599
[TBL] [Abstract][Full Text] [Related]
2. Large-scale preparation, purification, and characterization of hyaluronan oligosaccharides from 4-mers to 52-mers.
Tawada A; Masa T; Oonuki Y; Watanabe A; Matsuzaki Y; Asari A
Glycobiology; 2002 Jul; 12(7):421-6. PubMed ID: 12122023
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer.
Basu A; Upadhyay P; Ghosh A; Bose A; Gupta P; Chattopadhyay S; Chattopadhyay D; Adhikary A
Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129841. PubMed ID: 33412224
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization by electrospray-ionization mass spectrometry and high-performance anion-exchange chromatography of oligosaccharides derived from hyaluronic acid by hyaluronate lyase digestion: observation of some heretofore unobserved oligosaccharides that contain an odd number of units.
Price KN; Al Tuinman ; Baker DC; Chisena C; Cysyk RL
Carbohydr Res; 1997 Sep; 303(3):303-11. PubMed ID: 9373935
[TBL] [Abstract][Full Text] [Related]
5. On-line HPLC/ESI-MS separation and characterization of hyaluronan oligosaccharides from 2-mers to 40-mers.
Volpi N
Anal Chem; 2007 Aug; 79(16):6390-7. PubMed ID: 17608452
[TBL] [Abstract][Full Text] [Related]
6. Characterizing the electrospray-ionization mass spectral fragmentation pattern of enzymatically derived hyaluronic acid oligomers.
Prebyl BS; Kaczmarek C; Tuinman AA; Baker DC
Carbohydr Res; 2003 Jun; 338(13):1381-7. PubMed ID: 12801711
[TBL] [Abstract][Full Text] [Related]
7. Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells.
Parmar MB; Meenakshi Sundaram DN; K C RB; Maranchuk R; Montazeri Aliabadi H; Hugh JC; Löbenberg R; Uludağ H
Acta Biomater; 2018 Jan; 66():294-309. PubMed ID: 29183848
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronic acid-coated pH sensitive poly (β-amino ester) nanoparticles for co-delivery of embelin and TRAIL plasmid for triple negative breast cancer treatment.
Xu Y; Liu D; Hu J; Ding P; Chen M
Int J Pharm; 2020 Jan; 573():118637. PubMed ID: 31550511
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic and chemical methods for the generation of pure hyaluronan oligosaccharides with both odd and even numbers of monosaccharide units.
Blundell CD; Almond A
Anal Biochem; 2006 Jun; 353(2):236-47. PubMed ID: 16624243
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic Acid-Targeted Stimuli-Sensitive Nanomicelles Co-Encapsulating Paclitaxel and Ritonavir to Overcome Multi-Drug Resistance in Metastatic Breast Cancer and Triple-Negative Breast Cancer Cells.
Gote V; Sharma AD; Pal D
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513992
[TBL] [Abstract][Full Text] [Related]
11. Mechanism for the hydrolysis of hyaluronan oligosaccharides by bovine testicular hyaluronidase.
Kakizaki I; Ibori N; Kojima K; Yamaguchi M; Endo M
FEBS J; 2010 Apr; 277(7):1776-86. PubMed ID: 20193045
[TBL] [Abstract][Full Text] [Related]
12. CD44 targeted redox-triggered self-assembly with magnetic enhanced EPR effects for effective amplification of gambogic acid to treat triple-negative breast cancer.
Sang M; Han L; Luo R; Qu W; Zheng F; Zhang K; Liu F; Xue J; Liu W; Feng F
Biomater Sci; 2019 Dec; 8(1):212-223. PubMed ID: 31674634
[TBL] [Abstract][Full Text] [Related]
13. On-line separation and characterization of hyaluronan oligosaccharides derived from radical depolymerization.
Zhao X; Yang B; Li L; Zhang F; Linhardt RJ
Carbohydr Polym; 2013 Jul; 96(2):503-9. PubMed ID: 23768593
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of defined oligohyaluronates-decorated liposomes and interaction with lung cancer cells.
Cano ME; Lesur D; Bincoletto V; Gazzano E; Stella B; Riganti C; Arpicco S; Kovensky J
Carbohydr Polym; 2020 Nov; 248():116798. PubMed ID: 32919536
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of hyaluronan oligosaccharides for angiogenesis study.
Gao F; Cao M; Yang C; He Y; Liu Y
J Biomed Mater Res B Appl Biomater; 2006 Aug; 78(2):385-92. PubMed ID: 16544303
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry for the characterization of unsulfated chondroitin oligosaccharides from 2-mers to 16-mers. Comparison with hyaluronic acid oligomers.
Volpi N; Zhang Z; Linhardt RJ
Rapid Commun Mass Spectrom; 2008 Nov; 22(22):3526-30. PubMed ID: 18853395
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of separated end hyaluronan oligosaccharides from leech hyaluronidase and evaluation of angiogenesis.
Lv M; Wang M; Cai W; Hao W; Yuan P; Kang Z
Carbohydr Polym; 2016 May; 142():309-16. PubMed ID: 26917404
[TBL] [Abstract][Full Text] [Related]
18. Sulfated modification of hyaluronan tetrasaccharide enhances its antitumor activity on human lung adenocarcinoma A549 cells in vitro and in vivo.
He X; Wang S; Liu B; Jiang D; Chen F; Mao G; Jin W; Pan H; Zhong W
Bioorg Med Chem Lett; 2022 Nov; 75():128945. PubMed ID: 35987509
[TBL] [Abstract][Full Text] [Related]
19. Syndecan-1 Depletion Has a Differential Impact on Hyaluronic Acid Metabolism and Tumor Cell Behavior in Luminal and Triple-Negative Breast Cancer Cells.
Valla S; Hassan N; Vitale DL; Madanes D; Spinelli FM; Teixeira FCOB; Greve B; Espinoza-Sánchez NA; Cristina C; Alaniz L; Götte M
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070901
[TBL] [Abstract][Full Text] [Related]
20. Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer.
Zhou DD; Bai WQ; Zhai XT; Sun LP; Zhen YS; Li ZR; Miao QF
Mil Med Res; 2021 Dec; 8(1):63. PubMed ID: 34879870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
